Erratum to "Bacterial toxins and Multiple Sclerosis" [J Neurol Sci 262 (2007) 105-112] (DOI:10.1016/j.jns.2007.07.002);Bacterial toxins and Multiple Sclerosis

Journal of the Neurological Sciences

Volumn 262, Issue 1-2, 2007, Pages 105-112

  Gay, Frederick ^a  

^a NATIONAL INSTITUTE OF AGRICULTURAL BOTANY   (United Kingdom)

Author keywords

Bacterial transportable toxins; Cerebrospinal fluid; Mucosal lymphatics; Multiple Sclerosis; Paranasal infections

Indexed keywords

BACTERIAL TOXIN; CELL PROTEIN; EXOTOXIN; HEAT SHOCK PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; T LYMPHOCYTE RECEPTOR;

ARACHNOIDITIS; ARTICLE; BLOOD BRAIN BARRIER; CAMPYLOBACTER JEJUNI; CENTRAL NERVOUS SYSTEM DISEASE; CEREBROSPINAL FLUID; DEMYELINATING DISEASE; DEMYELINATION; EXTRACELLULAR FLUID; EXTRACELLULAR SPACE; HUMAN; IMMUNE RESPONSE; LYMPHATIC DRAINAGE; MULTIPLE SCLEROSIS; NOSE DISEASE; OPTIC CHIASM; OPTIC NEURITIS; PATHOGENESIS; PRIORITY JOURNAL; RHINOPHARYNGITIS; TOXIN ANALYSIS; VIRCHOW ROBIN PERIVASCULAR SPACE;

EID: 34548552943     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2008.07.022     Document Type: Erratum

References (80)

1. Compston A. The story of multiple sclerosis. In: Compston A., Ebers G., Lassmann H., et al. (Eds). McAlpine's multiple sclerosis (1998), Churchill Livingstone, Edinburgh 3-42
2. Compston A., and Coles A. Multiple sclerosis. Lancet 359 (2002) 1221-1231 [Seminar]
3. Acheson E. The epidemiology of multiple sclerosis. In: Matthews W., Acheson E., Batchelor J., et al. (Eds). McAlpine's multiple sclerosis (1985), Churchill Livingstone, Edinburgh 3-46
4. Mimms C. Viral aetiology of diseases of obscure origin. Br Med Bull 41 (1985) 63-69
5. Gilden D. Viruses and multiple sclerosis. J Am Med Assoc 286 (2001) 3127-3129 [Editorial]
6. Owens G., Kraus H., Burgoon M., Smith-Jensen T., Devlin M., and Gilden D. Restricted use of VH4 germline segments in an acute Multiple Sclerosis brain. Ann Neurol 43 (1998) 236-243
7. Tsai J., and Gilden D. Chlamydia pneumoniae and multiple sclerosis: no significant association. Trends Microbiol 9 (2001) 152-154
8. Drake C., and Kotzin B. Superantigens: biology, immunology, and potential role in disease. J Clin Immunol 12 (1992) 149-162
9. Morris J.A. Clinical viral infections and multiple sclerosis. Lancet 2 (1985) 273
10. Friedman S., Posnett D., Tumang J., Cole M., and Crow M. A potential role for microbial superantigens in the pathogenesis of systemic autoimmune disease. Arthritis Rheum 34 (1991) 468-480
11. Brocke S., Gour A., Piercy C., Gautam A., Gijbels K., Fathman C., et al. Induction of relapsing paralysis in experimental autoimmune encephalomyelitis by bacterial superantigen. Nature 365 (1993) 642-644
12. Burns J., Littlefield K., Gill J., and Trotter J. Bacterial toxin superantigens activate human T lymphocytes reactive with myelin autoantigens. Ann Neurol 32 (1992) 352-357
13. Aasjord P., Nyland H., and Haaheim L. Intrathecal synthesis of antibodies to Staphylococcal antigens in Multiple Sclerosis patients. Acta Pathol Microbiol Immunol Scand 94 (1986) 97-103
14. Utz U., Biddison W., McFarland H., McFarlin D., Flerlage M., and Martin R. Skewed T-cell receptor repertoire in genetically identical twins correlates with multiple sclerosis. Nature 364 (1993) 243-247
15. Kotzin B. Twins and T-cell responses. Nature 364 (1993) 187-188
16. Ransohoff R., and Rudick D. Heat-shock proteins and autoimmunity: implications for multiple sclerosis. Ann Neurol 34 (1993) 5-7
17. Hughes R., and Cornblath D. Guillain-Barre syndrome. Lancet 366 (2005) 1653-1666
18. Hays A., Lee S., and Latov N. Immune reactive C3d on the surface of myelin sheaths in neuropathy. J Neuroimmunol 18 (1988) 321-344
19. Linial M. Bacterial neurotoxins - a thousand years later. Isr J Med Sci 31 (1995) 591
20. Lassmann H. Brain damage when Multiple Sclerosis is diagnosed clinically. Lancet 361 (2003) 1317-1318
21. Trapp B. Pathogenesis of Multiple Sclerosis: the eyes only see what the mind is prepared to comprehend. Ann Neurol 55 (2004) 455-457 [Editorial]
22. Filippi M., Bozzali M., Rovaris M., Gonen O., Kesavadas C., Ghezzi A., et al. Evidence for widespread axonal damage at the earliest clinical stage of multiple sclerosis. Brain 126 (2003) 433-437
23. Compston A. Treatment and management of multiple sclerosis. In: Compston A., Ebers G., Lassmann H., et al. (Eds). McAlpine's multiple sclerosis (1998), Churchill Livingstone, Edinburgh 437-498
24. Filippini G., Munari L., Incorvala B., Ebers G., Polman C., D'Amico R., et al. Interferons in relapsing remitting Multiple Sclerosis: a systematic review. Lancet 361 (2003) 545-552
25. Ferguson B., Matyszak M., Esiri M., and Perry V. Axonal damage in acute multiple sclerosis lesions. Brain 120 (1997) 393-399
26. Evangelou N., Esiri M., Smith S., Palace J., and Matthews P. Quantitative pathological evidence for axonal loss in normal appearing white matter in multiple sclerosis. Ann Neurol 47 (2000) 391-395
27. Bjartmar C., Kinkel R., Kidd G., Rudick R., and Trapp B. Axonal loss in normal appearing white matter in a patient with acute MS. Neurology 57 (2001) 1248-1252
28. Barnett M., and Prineas J. Relapsing and remitting Multiple Sclerosis: pathology of the newly forming lesion. Ann Neurol 55 (2004) 458-468
29. Gay F.W. Early cellular events in Multiple Sclerosis. Intimations of an extrinsic myelinolytic antigen. Clin Neurol Neurosurg 108 (2006) 234-240
30. McKeown S., and Allen I. The cellular origin of lysosomal enzymes in the plaque in Multiple Sclerosis: a combined histological and biochemical study. Neuropathol Appl Neurobiol 4 (1978) 471-482
31. Adams C. The onset and progression of the lesion in multiple sclerosis. J Neurol Sci 25 (1975) 165-182
32. Werring D., Brassat D., Droogan A., Clark C., Symms M., Barker G., et al. The pathogenesis of lesions and normal appearing white matter changes in Multiple Sclerosis. A serial diffusion MRI study. Brain 123 (2000) 1667-1682
33. Filippi M., Tortorella C., and Bozzali M. Normal appearing white matter changes in Multiple Sclerosis: the contribution of magnetic resonance techniques. Mult Scler 5 (1999) 273-282
34. Marburg O. Die sogennante 'akute multiple sklerose'. J f Psychi Neurol 27 (1906) 211-312
35. Dawson J. The histology of disseminated sclerosis. Trans Roy Soc Edin 50 (1916) 517-740
36. Lumsden C. Pathology of multiple sclerosis. In: McAlpine D., Compston N., and Lumsden C. (Eds). McAlpine's multiple sclerosis (1955), Livingstone, Edinburgh 208-239
37. Lee S., Moore G., Golenwsky G., and Raine C. A role for astroglia in active demyelination suggested by Class II MHC expression and ultrastructural study. J Neuropathol Exp Neurol 49 (1990) 122-136
38. Adams C. Demyelinating and other myelin diseases in man. In: Adams C. (Ed). A colour atlas of Multiple Sclerosis and other myelin disorders (1989), Wolfe Medical, London 27-65
39. Bo L., Vedeler C., Nyland H., Trapp B., and Mork S. Subpial demyelination in the cerebral cortex of multiple sclerosis patients. J Neuropathol Exp Neurol 62 (2003) 723-732
40. Adams C. Histochemical contributions to the study of multiple sclerosis. In: Stowars P., and Polak J. (Eds). Histochemistry: the widening horizons (1981), John Wiley and Sons, Chichester 163-182
41. Ali ibn I. Tadhkirat al-kahhalin. In: Hirschberg J., Lippert J., and Mittwoch E. (Eds). Die arabischen Augenarte nach den Quellen (1904), Verlag von veit Comp., Leipzig
42. White L. Loss of sight from posterior accessory sinus disease with report of three cases. Boston Med Surg J 176 (1917) 891-899
43. Crane C. The anatomic, pathologic and clinical relationship of the posterior sinuses to optic neuritis. Ann Otol Rhinol Laryngol 36 (1927) 201-240
44. Baratoux J. A propos des troubles oculaires dans les sinusites specialment, les sinusites sphenoidales, les sinusites latentes et de l'ouverture du sinus sphenoidal. Monographies médicales 15 (Dec 1923) 59-67
45. Canuyt, Ramadier, and Velter. Les sinusitis posterieures et leurs complications oculaires. Annales des Maladies de l'oreille et du larynx 44 39 and 140 (1925)
46. Thomson E. Conditions of the optic nerve caused by disease of the sinuses. Arch Otolaryngol 10 (1929) 248-261
47. Gifford S. The relation of the paranasal sinuses to ocular disorders, especially to retrobulbar neuritis. Trans Am Acad Ophthalmol Otolaryngol 48 (1930) 276-286
48. Herzog H. Uber die neuritis retrobulbularis. Arch f Augenheilkunde 99 (1928) 292-321
49. McMahon B. Pathology of spheno-ethmoidal sinusitis. Arch Otolaryngol 4 (1926) 310-333
50. Sluder G. Headaches and eye disorders (1927), Mosby & Co., St Louis
51. Oliver K., and Crowe S. Retrobulbar neuritis and infection of the accessory nasal sinuses. Arch Otolaryngol 6 (1927) 503-525
52. Onodi L. The optic nerve and accessory cavities of the nose. Ann Laryngol Rhinol Otol 6 (1908) 503-525
53. Loeb H. A study of the anatomic relations of the optic nerve to the accessory cavities of the nose. Ann Otol Rhinol Laryngol 18 (1909) 243-276
54. Schaeffer J. The nose, paranasal sinuses, nasolacrymal passageways and olfactory organ in man (1920), Blakiston, Philadelphia
55. Van Alyea O. Sphenoid sinus: anatomic study, with consideration of the clinical significance of the structural characteristics of the sphenoid sinus. Arch Otolaryngol 34 (1941) 225
56. Vail H. Retrobulbar optic neuritis originating in the nasal sinuses. A new method of demonstrating the relation between the sphenoid sinus and the optic nerve. Arch Otolaryngol 13 (1931) 846-863
57. Vail D. Optochiasmatic arachnoiditis: importance of a mixed type of atrophy of the optic nerve as a diagnostic sign. Arch ophthalmol 20 (1938) 383-394
58. Balado M., and Satanowski P. Tratamiento quirugico de la papila. Arch Argent Neurol 4 (1929) 71-75
59. Bell R., Robertson D., Rosen D., and Kerr A. Optochiasmatic arachnoiditis in multiple sclerosis. Arch Ophthalmol 93 (1975) 191-193
60. Orr D., and Rose R. Lymphogenous infection of the central nervous system. Brain 36 (1914) 271-340
61. Doery H., Magnusson B., Gulasekharam J., and Pearson J. The properties of phospholipase enzymes in Staphylococcal toxins. J Gen Microbiol 40 (1965) 283-296
62. Song L., Hobaugh M., Shustak C., Cheley S., Bayley H., and Gouaux E. Structure of Staphylococcal α haemolysin, a heptameric transmembrane pore. Science 274 (1996) 1859-1866
63. Zager R., Burkhart K., and Johnson A. Sphingomyelinase and membrane sphingomyelin content. Determinants of proximal tubule cell susceptibility to injury. J Am Soc Nephrol 11 (2000) 894-902
64. Brunner H. Rhinogenic retrobulbar neuritis. Laryngoscope 51 (1941) 903-929
65. Shibasaki H., McDonald W., and Kuroiwa Y. Racial modification of clinical picture of Multiple Sclerosis: comparison between British and Japanese patients. J Neurol Sci 49 (1981) 253-271
66. Genain C., and Hauser S. Experimental allergic encephalomyelitis in the New World monkey Collithrix jaccus. Immunol Rev 183 (2001) 159-172
67. Tarkkanen J., and Tarkkanen A. Otolaryngological pathology in patients with optic neuritis. Acta Ophthalmol 49 (1971) 649-657
68. Awerbuch G., Labadie E., and Van Dalen J. Reversible optic neuritis secondary to paranasal sinusitis. Eur Neurol 29 (1989) 189-193
69. Rothstein J., Maisel R., Berlinger N., and Wirtschafter J. Relationship of optic neuritis to disease of the paranasal sinuses. Laryngoscope 94 (1984) 1501-1508
70. Gay D., Dick G., and Upton G. Multiple Sclerosis associated with sinusitis. A case controlled study in general practice. Lancet i (1986) 815-819
71. Callaghan T. Multiple sclerosis and sinusitis. Lancet ii (1986) 160
72. Bradley W., and Whitty C. Acute optic neuritis: its clinical features and their relation to prognosis for recovery of vision. J Neurol Neurosurg Psychiat 30 (1967) 531-538
73. Martyn C. The epidemiology of multiple sclerosis. In: Matthews W., Compston A., Allen I., et al. (Eds). McAlpine's multiple sclerosis (1991), Churchill Livingstone, Edinburgh 31
74. Broadwell R., and Sofroniew M. Serum proteins bypass the blood brain barrier for extracellular entry to the central nervous system. Exp Neurol 120 (1993) 245-263
75. Foldi M. Pre-lymphatic drainage of the brain. Am Heart J 93 (1977) 121-124
76. Esiri M., and Gay D. Immunological and neuropathological significance of the Virchow-Robin space. J Neurol Sci 100 (1990) 3-8
77. Prineas J. Multiple Sclerosis: presence of lymphatic capillaries and lymphoid tissue in the brain and spinal cord. Science 203 (1979) 1123-1125
78. Bruce A., and Dawson J. Preliminary communication on the pathology of disseminated sclerosis. J Pathol Bacteriol XV (1911) 126
79. Serafini B., Rosicarelli B., Magliozzi R., Stigliano E., and Aloisi F. Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis. Brain Pathol 14 (2004) 164-174
80. Gay F. Activated microglia in primary MS lesions: defenders or aggressors?. Internat MS J 14 (2007) 76-82